Search AGTX
Agentix Corp.
OTC · CIK 1603345
Last close0.02
Daily change+0.00 (0.00%)
10 Years gain-99.89%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
AGTX · STANDARD
SIC 2836 · Biological Products, (No Diagnostic Substances) · Fiscal year end 0331
Fundamental
13.2Momentum
n/aAcceleration
n/aConfidence
62.0Annual Revenue6
Quarterly Revenue18
Annual CFO12
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth0.0 / 25
Quality12.5 / 25
Capital Efficiency0.0 / 20
Balance Sheet0.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
No positive signals calculated.
Key Metrics
Revenue Growth TTMn/aINSUFFICIENT_HISTORY
Revenue CAGR 3Yn/aINSUFFICIENT_HISTORY
Gross Margin54.76%OK
Operating Marginn/aMISSING
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Yn/aINSUFFICIENT_HISTORY
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 FY Mar 31, 2026 | n/a | $0.00 | -$445,187.00 | -$108,529.00 | n/a | n/a | n/a | n/a | n/a | 40.07M |
| 2026 FY Mar 31, 2025 | n/a | $0.00 | -$513,251.00 | -$125,078.00 | n/a | n/a | n/a | n/a | n/a | 40.07M |
| 2025 FY Mar 31, 2024 | n/a | $0.00 | -$744,810.00 | -$110,429.00 | n/a | n/a | n/a | n/a | n/a | 40.07M |
| 2024 FY Mar 31, 2023 | n/a | $0.00 | -$1.37M | -$88,541.00 | n/a | n/a | n/a | n/a | n/a | n/a |
| 2023 FY Mar 31, 2023 | $0.00 | $0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $1,240.00 | sum latest 4 fiscal quarters Revenue | OK | 0001477932-22-008435, 0001477932-23-000969 |
| Revenue Growth TTM | n/a | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | INSUFFICIENT_HISTORY | 0001477932-22-008435, 0001477932-23-000969 |
| Revenue CAGR 3Y | n/a | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001477932-23-005252 |
| Revenue CAGR 5Y | n/a | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | INSUFFICIENT_HISTORY | 0001477932-23-005252 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001477932-23-005252 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 54.76% | Gross Profit / Revenue | OK | 0001477932-22-008435, 0001477932-23-000969 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | derived |
| Current Ratio | 0.06x | Current Assets / Current Liabilities | OK | derived |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | derived |
| Diluted EPS TTM | n/a | Net income TTM / Diluted shares | NOT_MEANINGFUL | derived |
| Gross Margin Delta 1Y | n/a | GrossMargin_current - GrossMargin_prior_year | INSUFFICIENT_HISTORY | 0001477932-22-008435, 0001477932-23-000969 |